Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee recommends approval of Novantrone for MS indication

Feb. 1, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Beclomethasone Clickhaler approved in France

Jan. 28, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

FDA approves new labeling for Hyalgan

Jan. 28, 2000

New growth hormone option increases patient convenience

Jan. 25, 2000

Genotropin delivery device now available for long-term replacement therapy in GHD

Jan. 24, 2000

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Jan. 21, 2000

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Jan. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...